Effects of methylprednisolone on bone formation and resorption in rats

Japanese Journal of Pharmacology

Volumn 90, Issue 3, 2002, Pages 236-246

  Wang, Yujiang ^a   Ohtsuka Isoya, Mie ^a   Shao, Ping ^a   Sakamoto, Seizaburo ^a   Shinoda, Hisashi ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

Bone formation; Bone resorption; Methylprednisolone; Osteoblast; Osteoclast

Indexed keywords

ALKALINE PHOSPHATASE; COLLAGEN; CORTICOSTEROID; GLUCOCORTICOID; METHYLPREDNISOLONE; OSTEOCALCIN; PROLINE; CALCIUM;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; BONE DENSITY; BONE MASS; BONE METABOLISM; BONE TURNOVER; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CORTICAL BONE; CORTICOSTEROID INDUCED OSTEOPOROSIS; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; ENCHONDRAL OSSIFICATION; MALE; METAPHYSIS; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PERIOSTEUM; PROTEIN BLOOD LEVEL; RAT; TIBIA; TRABECULAR BONE; ADIPOCYTE; ANIMAL; AUTORADIOGRAPHY; BLOOD; BONE DEVELOPMENT; BONE MARROW; CELL COUNT; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; PATHOLOGY; WISTAR RAT;

ADIPOCYTES; ANIMALS; AUTORADIOGRAPHY; BONE DENSITY; BONE MARROW; BONE RESORPTION; CALCIUM; CELL COUNT; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOCORTICOIDS; MALE; METHYLPREDNISOLONE; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; RATS; RATS, WISTAR;

EID: 1842831747     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.90.236     Document Type: Article

References (42)

1. Dykman TR, Gluck OS, Murphy WA, Hahn TJ and Hahn BH: Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum 28, 361-368 (1985)
2. Adinoff AD and Hollister JR: Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med 309, 265-268 (1983)
3. Lukert BP and Raisz LG: Glucocorticoid-induced osteoporosis: Pathogenesis and management. Ann Intern Med 112, 352-364 (1990)
4. Dietrich JW, Canalis EM, Maina DM and Raisz LG: Effects of glucocorticoids on fetal rat bone collagen synthesis in vitro. Endocrinology 104, 715-721 (1979)
5. Canalis E: Effect of glucocorticoids on type I collagen synthesis, alkaline phosphatase activity and deoxyribonucleic acid content in cultured rat calvariae. Endocrinology 112, 931-939 (1983)
6. Canalis E: Effect of cortisol on periosteal and nonperiosteal collagen and DNA synthesis in cultured rat calvariae. Calcif Tissue Int 36, 158-166 (1984)
7. Chyun YS and Raisz LG: Stimulation of bone formation by prostaglandin E2. Prostaglandins 27, 97-103 (1984)
8. Dempster DW, Arlot MA and Meunier PJ: Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis. Calcif Tissue Int 35, 410-417 (1983)
9. Lund B, Storm TL, Lund B, Melsen F, Mosekilde L, Andersen RB, Egmose C and Sorensen OH: Bone mineral loss, bone histomorphometry and vitamin D metabolism in patients with rheumatoid arthritis on long-term glucocorticoid treatment. Clin Rheumatol 4, 143-149 (1985)
10. Aota S, Nakamura T, Suzuki K, Tanaka Y, Okazaki Y, Segawa Y, Miura M and Kikuchi S: Effects of indomethacin administration on bone turnover and bone mass in adjuvant-induced arthritis in rats. Calcif Tissue Int 59, 385-391 (1996)
11. Bonnet J, Zerath E, Picaud N, Lesur C, Mattio A, Tordjman C, Hott M and Marie PJ: Bone morphometric changes in adjuvant-induced polyarthritic osteopenia in rats: Evidence for an early bone formation defect. J Bone Miner Res 8, 659-668 (1993)
12. Segawa Y, Nakamura T, Aota S, Tanaka Y, Yoshida K, Tsuzuike N and Matsuda K: Changes in urinary deoxypyridinoline level and vertebral bone mass in the development of adjuvant-induced arthritis in rats. Bone 17, 57-62 (1995)
13. Kimberg DV, Baerg RD, Gershon E and Graudusius RT: Effect of cortisone treatment on the active transport of calcium by the small intestine. J Clin Invest 50, 1309-1321 (1971)
14. 2+ absorption. Biochim Biophys Acta 274, 179-188 (1972)
15. Lukert BP, Stanburg SW and Mawer EB: Vitamin D and intestinal transport of calcium: Effect of prednisolone. Endocrinology 93, 718-722 (1973)
16. 3. Proc Natl Acad Sci USA 71 2996-3000 (1974)
17. Favus MJ, Kimberg DV, Millar GN and Gershon E: Effects of cortisone administration on the metabolism and localization of 25-hydroxycholecalciferol in the rat. J Clin Invest 53, 1328-1335 (1973)
18. Klein RG, Arnaud SB, Gallagher JC, DeLuca HJ and Riggs BL: Intestinal calcium absorption in exogenous hypercortisonism. J Clin Invest 60, 253-259 (1977)
19. Fox J, Care AD and Blahos J: Effects of low calcium and low phosphorus diets on the duodenal absorption of calcium in betamethasone-treated chicks. J Endocrinol 78, 255-260 (1978)
20. Sakakura M, Takebe K and Nakagawa S: Inhibition of luteinizing hormone secretion induced by synthetic LRH by long-term treatment with glucocorticoids in human subjects. J Clin Endocrinol Metab 40, 774-779 (1975)
21. Sombrook PN, Eisman JA, Champion GD and Pocock NA: Sex hormone status and osteoporosis in postmenopausal women with rheumatoid arthritis. Arthritis Rheum 31, 973-978 (1988)
22. Fujita T, Satomura A, Hidaka M, Ohsawa I, Endo M and Ohi H: Acute alteration in bone mineral density and biochemical markers for bone metabolism in nephrotic patients receiving high-dose glucocorticoid and one-cycle etidronate therapy. Calcif Tissue Int 66, 195-199 (2000)
23. Villareal MS, Klaustermeyer WB, Hahn TJ and Gordon EH: Osteoporosis in steroid-dependent asthma. Ann Allerg Asthma Immunol 76, 369-372 (1996)
24. King CS, Weir EC, Gundberg CW, Fox J and Insogna KL: Effects of continuous glucocorticoid infusion on bone metabolism in the rat. Calcif Tissue Int 59, 184-191 (1996)
25. Turner RT, Hannon KS, Greene VS and Bell NH: Prednisone inhibits formation of cortical bone in sham-operated and ovariectomized female rats. Calcif Tissue Int 56, 311-315 (1995)
26. Okazaki Y, Tsurukami H, Nishida S, Okimoto N, Aota S, Takeda S and Nakamura T: Prednisolone prevents decreases in trabecular bone mass and strength by reducing bone resorption and bone formation defect in adjuvant-induced arthritic rats. Bone 23, 353-360 (1998)
27. Shinoda H, Shoji K and Suzufuji K: Simple and rapid determination of bone mineral content in small experimental animals. Tohoku Univ Dent J 13, 122-129 (1994)
28. Shoji K, Ohtsuka-Isoya M, Horiuchi H and Shinoda H: Bone mineral density of alveolar bone in rats during pregnancy and lactation. J Periodontol 71, 1073-1078 (2000)
29. Minkin C: Bone acid phosphatase: Tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif Tissue Int 34, 285-290 (1982)
30. Chen PC, Toribara TY and Warner H: Microdetermination of phosphate. Anal Chem 28, 1756-1758 (1956)
31. Pearce G, Tabensky DA, Delmas PD, Baker HW and Seeman E: Corticosteroid-induced bone loss in men. J Clin Endocrinol Metab 83, 801-806 (1998)
32. Chiodini I, Carnevale V, Torlontano M, Fusilli S, Guglielmi G, Pileri M, Modoni S, Di Giorgio A, Liuzzi A, Minisola S, Cammisa M, Trischitta V and Scillitani A: Alterations of bone turnover and bone mass at different skeletal sites due to pure glucocorticoid excess: Study in eumenorrheic patients with Cushing's syndrome. J Clin Endocrinol Metab 83, 1863-1867 (1998)
33. Yasumura S: Effect of adrenal steroids on bone resorption in rats. Am J Physiol 230, 90-93 (1976)
34. Ferretti JL, Vazquez SO, Delgado CJ, Capozza R and Cointry G: Biphasic dose-response curves of cortisol effects on rat diaphyseal bone biomechanics. Calcif Tissue Int 50, 49-54 (1992)
35. Peretz A, Praet JP, Bosson D, Rozenberg S and Bourdoux P: Serum osteocalcin in the assessment of corticosteroid-induced osteoporosis. Effect of long- and short-term corticosteroid treatment. J Rheumatol 16, 363-367 (1989)
36. Weinstein RS, Jilka RL, Parfitt AM and Manolagas SC: Inhibition of osteoblastgenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanism of their deleterious effects on bone. J Clin Invest 102, 274-282 (1998)
37. Delany AM, Dong Y and Canalis E: Mechanisms of glucocorticoid action in bone cells. J Cell Biochem 56, 295-302 (1994)
38. Scutt A, Bertram P and Brautigam M: The role of glucocorticoids and prostaglandin E2 in the recruitment of bone marrow mesenchymal cells to the osteoblastic lineage: Positive and negative effects. Calcif Tissue Int 59, 154-162 (1996)
39. Boden SD, Hair G, Titus L, Racine M, McCuaig K, Wozney JM and Nanes MS: Glucocorticoid-induced differentiation of fetal rat calvarial osteoblasts is mediated by bone morphogenetic protein-6. Endocrinology 138, 2820-2828 (1997)
40. Nuttall ME, Patton AJ, Olivera DL, Nadeau DP and Gowen M: Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: Implications for osteopenic disorders. J Bone Miner Res 13, 371-382 (1998)
41. Nuttall ME and Gimble JM: Is there a therapeutic opportunity to either prevent or treat osteopenic disorders by inhibiting marrow adipogenesis? Bone 27, 177-184 (2000)
42. Sabatakos G, Sims NA, Chen J, Aoki K, Kelz MB, Amling M, Bouali Y, Mukhopadhyay K, Ford K, Nestler EJ and Baron R: Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis. Nat Med 6, 985-990 (2000)